1.5 tirzepatide 5mg Tirzepatide Unlikely to Exacerbate DR

10.1016/S2213-8587(21)00203-5 22

The clinical investigators specifically noted that "gastrointestinal adverse events were partially mitigated by the use of a lower starting dose." Starting at 1 mg, which is what the Phase 3 TRIUMPH trials use, provides even more tolerability protection

How to Do It: Stand parallel to a weight bench with a weight in your left hand

Our highly trained medical staff has the expertise to provide this treatment safely and effectively, ensuring that you leave our med spa feeling revitalized and refreshed

Others require a higher dose to get the full appetite-suppressing effect

doi: 10.1111/dom.13327